Member Info for David1951c

Tim,
As a minor SH ((400k shares) I can say that I hope the existing board will be prepared to listen to all views and not hold a grudge against those trying to change the company for the best. Hopefully also there can be a consensus on the best way forward.
Shareholders want regular and honest communication and to have some idea of what the strategic objectives and key steps are and when things will happen. Hope that's not asking too much!

Not a deramper as I hold nearly 1m shares and have been in for nearly three years but delays are frustrating. I still don't see why the new website should take so long or a prospectus six months when BMV have done two already.
Most of the BS comes from BS but a more dynamic approach is needed driven by the BoD to get things done.

40%+ voted for the resolutions 1-8 so the Board have to take notice of the discontent. If the Board do actually work with the large shareholders putting forward the resolutions and take the company forward more dynamically it could be a win win for all shareholders. ED was poor and hopefully MR will be much more successful as a leader and deliverer.
If the work over works and with the much higher gas price, it could mean a much needed and quicker revival in the company and the SP.
Await to hear from TA.

not much on timescales. More news in "coming months" does not show much urgency. Really need to see faster concrete progress with all the projects. Announcements are great news but wording does not project a dynamic push to get the projects done.

Bought a small amount 400k shares more than three years ago tempted by the potential of Tesorillo project possibly with large gas reserves. In the current gas price scenario and with Spain pushing hard for EU gas purchases due to public reaction to v. high gas prices, I wonder what the intentions are for that project to be moved forward quickly. If successful it would dwarf the other minority holdings in Italy and Spain.
I was glad when ED departed as he was unimpressive as a CEO both in presentations and failing to deliver and I prefer MR to Koots where I lost a bit on Cerps. Need to decide how to vote today.

Invested a while ago a small amount (£5k) in QFI due to interest in a spread of greener companies including AFC and INV. Latest news suggests that the company has significant potential. Is there any information on the partnership in terms of roles and revenue sharing: Could QFI earn say $10 for each bopd?

Results should be promising and hopefully the post period update will give more confidence the company is moving forward and strategy is working. Unsure why the SP is a little volatile but it may be AIM which has SP dips on a small number of sells or a large shareholder is reducing. Medium to longer term revenue and EBITA should be rising steadily to support a SP over £2.

RNS in August 2020 referred to the development of commercial MSAR® plants of up to 10,000 barrels oil per day ("Phase 2") located at Utah facilities owned or operated by Greenfield.
Looking forward to much faster progress to make this happen.

Clearly TW loathes GB and these attacks undermine confidence as in part may be true. Many companies are too optimistic and it is important to evaluate the financial performance as well as the prospects. Personally I prefer to have more engagement from the boss but perhaps for a while it went too far.
The critical issue is that following the June raise the company should have enough cash to get to sustained profitability. Operating loss of £2.3m is covered by cash for at least 18 months but if the outlook and expectations are met DVRG should be in profit with a lot to potentially come from the developments already announced. If the loss is financing higher growth then that is an investment with potentially much higher reward.
Never easy for investors to decide but having been a SH for over 3 years I think holding for another 12 months should pay off.

Dined at Real Greek in St. Martin's Lane last week. Advert in front window for more staff at all levels. Hope growth not held back by too many unfilled vacancies.
Re-reading results reinforces the view that the company's prospects have never been better. Expansion should be rapid at low costs as it is a renter's market with landlords falling over to get new tenants and fit-out costs in some locations minimised where taking over an existing restaurant. Real Greek don't spend inordinate amounts on interiors.
It seems likely there will be another 12 or more locations in next 12 months and the chairman said financing will be by cash flow and banking facilities rather than dilution so FS looks a stable and growing business from an investor's point of view.

It would be helpful if estimated timescales for assay results were also provided in RNS. They must have some idea!

Agree. More contract announcements are probable as well as updates on spin offs. Even though they may not happen until 2022 some of the preparation and steps should be announced in Q4. Under promising and over delivery will hopefully be a more stable and exciting period ahead.

If data on LSE is correct six sells totalling less than 20k shares cause a disproportionate SP drop. AIM pricing methodology is nuts! I spoke too soon about stability. These drops have enabled me to buy a few more before and medium term (1 year) SP will recover to well over £2 in my view. Just need better completion of pipeline and regular news flow. CDT lung test also has great potential.

Results for Y/e 31 May are expected at the end of October based on previous two years. With a lot going on and such a large pipeline (see June trading update) I was expecting more regular news flow and ONC could issue a quarterly trading update to keep shareholders better informed. Apparent delays in completing contracts are disappointing but this has always been a long term hold. Thankfully not too much trading and SP is relatively stable.

The lack of clarity on the real benefits to EQT of this agreement almost inevitably leads to doubts that it is a good deal because Kibo is a minnow. Slow progress with numerous projects does not help and on AIM regular updates tend to support a sustained higher SP. I am fairly confident that this will come good but there is pain on this journey. What EQT must do is issue the next quarterly update as soon as possible in October to reassure shareholders.

Kibo are an underwhelming partner with Mcap of only £6m so presumably EQT have done full due diligence before reaching the agreement. Pity they could not find a much more substantial partner. Even with the hint of future prospects in Africa, there is little to get excited about and questions remain on financing and timescales. For EQT to make real progress, earn serious revenues and realise their potential. it needs more concrete attainments than visible right now. Some valid questions have been raised. Next quarterly update is due in four weeks or so and hopefully EQT will address shareholders questions and concerns.

I did try to post a correction but not sure where it went! Phase 3s (threes) are expected to start in 2022. Phase 2's were completed on leading candidates with great outcomes.

SP has dropped again today and it's a bit more than adrift! If the Board and management don't understand the disappointment and frustration among small shareholders I would be surprised but they really need to get a move on and communicate with us. Show more dynamism and get moving. So slow on the new website and saying six months to prepare the third prospectus is quite ridiculous.

sorry Phase 3s to start in 2022. Phase 2s for main assets already completed.

No major surprises or news in results or update in webinar. Phase 2s expected to start in H2 2022 with partner discussions under way. Funded until end of 2022. NC said that a company with late stage assets like their's would value the company at around $500m. Very positive looking ahead and with excellent assets both in P3 and additional ones in pre clinical development. Given the area of work the company has excellent prospects.